EIF2AK4 and colitis: Conversely, GCN2 activation by amino acid restriction significantly protects against DSS colitis by inhibiting reactive oxygen species-mediated inflammasome activation, suppressing pathogenic Th17 response and promoting autophagy to reduce inflammation (Ravindran et al., 2016; Revelo et al., 2016).